Clinical efficacy of benidipine for vasospastic angina pectoris

Arzneimittel-Forschung/Drug Research

Volumn 57, Issue 1, 2007, Pages 20-25

  Suzuki, Hiromasa ^a   Yokoyama, Ken ^a   Akimoto, Yoshinori ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Angina attack; Benidipine, anti vasospastic efficacy, clinical trial; Ca channel blocker; CAS 91599 74 5; Coniel ; Diltiazem; Nitric oxide; Variant angina pectoris; Vasospastic angina pectoris

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRATE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; BRADYCARDIA; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG SUBSTITUTION; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HUMAN; HYPOTENSION; MALE; PARAMETER; TREATMENT OUTCOME; VASOSPASM;

EID: 33846807576     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296581     Document Type: Article

References (20)

1. Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease. 7th ed. Philadelphia: Elsevier/Saunders; 2005.
2. Shimokawa H, Nagasawa K, Irie T, Egashira S, Egashira K, Sagara T, et al. Clinical characteristics and long term prognosis of patients with variant angina: a comparative study between western and Japanese populations. Int J Cardiol. 1988;18:331-349.
3. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101:1102-1108.
4. Suzuki H, Kawai S, Aizawa T, Kato K, Sunayama S, Okada R, et al. Histological evaluation of coronary plaque in patients with variant angina: relationship between vasospasm and neointimal hyperplasia in primary coronary lesions. J Am Coll Cardiol. 1999;33:198-205.
5. Karasawa A, Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol. 1988;47(1):35-44.
6. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Pharmacological actions of benidipine hydrochloride in several isolated smooth muscles and myocardium. Arzneimittel-Forschung (Drug Research). 1988;38:1722-1730.
7. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Anti-anginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study. Arzneimittel-Forschung (Drug Research). 1988:38:1702-1707.
8. Kitayama J, Kitazono T, Ooboshi H, Takada J, Fujishima M, Ibayashi S. Long-term effects of benidipine on cerebral vasoreactivity in hypertensive rats. Eur J Pharmacol. 2002; 8:153-158.
9. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
10. Honma M, Satoh T, Takezawa J, Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med. 1977;18:257-273.
11. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864-2870.
12. Kitakaze M, Node K, Minamino T, Asanuma H, Kuzuya T, Hori M. A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs. J Am Coll Cardiol. 1999;33:242-249.
13. Kobayashi N, Kobayashi K, Hara K, Higashi T, Yanaka H, Yagi S, et al. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am J Hypertens. 1999;12:483-491.
14. Ito A, Fukumoto Y, Shimokawa H. Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol. 2004;44:480-485.
15. Suzuki K, Imada T, Gao F, Ma H, Nagata T. Radioautographic study of benidipine hydrochloride. Localization in the mesenteric artery of spontaneously hypertensive rat. Arzneimittel-Forschung (Drug Research). 1994;44:129-133.
16. 3H]benidipine hydrochloride to rat heart membranes. J Cardiovasc Pharmacol. 1993;21(2):191-196.
17. Furukawa T, Nukada T, Miura R, Ooga K, Honda M, Watanabe S, et al. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol. 2005;45:241-246.
18. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation. 1996;94:266-271.
19. Takase H, Sugiyama M, Nakazawa A, Sato K, Ueda R, Dohi Y. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension. Arzneimittel-Forschung (Drug Research). 2000;50:530-534.
20. Katoh A, Ikeda H, Takajo Y, Haramaki N, Murohara T, Shintani S, et al. Coexistence of Impairment of Endothelium-Derived Nitric Oxide and Platelet-Derived Nitric Oxide in Patients With Coronary Risk Factors. Circ J. 2002;66:837-840.